A patient with B-cell acute lymphoblastic leukaemia has become the first adult to receive a pioneering cell therapy on the NHS...
CRISPR/Cas9 genome editing has been used in mice to investigate two key genes' roles in male fertility and sperm production...
A new genome editing approach has been shown to safely and efficiently remove the source of transthyretin amyloidosis in mice, demonstrating greater therapeutic opportunities for genome editing...
A heart attack patient has become the first person to be treated in a clinical trial of an experimental gene therapy, which aims to strengthen blood vessels after coronary bypass surgery...
A large-scale study has unveiled genes essential for early brain development and uncovered the cause of a previously unrecognised neurodevelopmental disorder...
Eleven people with aggressive T-cell leukaemia have now received a 'base editing' therapy, with seven remaining in remission up to three years after treatment...
Data on the effectiveness and safety of Casgevy gene therapy in children aged five to 11 years has been reported...
Bringing you PET events as a podcast. In the 38th episode of its podcast, PET explores how to improve diagnosis, treatment and support for people affected by rare and inherited metabolic diseases...
CRISPR-based genome editing has been used to overcome chemotherapy resistance in lung tumours by disabling a tumour-specific mutation...
A new multipurpose genome editing approach could address around a third of rare genetic diseases...
Subscribe for free to what PET does best – informing you of the latest in fertility, genomics and embryo research.
